• PIN34 - COMPARING THE ESTIMATED PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF PHID-CV AND PCV-13 IN THE ROUTINE IMMUNISATION PROGRAMME IN GAVI-ELIGIBLE COUNTRIES (SUB-SAHARAN AFRICA AND ASIA/OCEANIA)- A MODELLING STUDY

    Oct 1, 2018, 00:00

  • PRS76 - DISEASE ADAPTATION AND PERCEIVED HEALTH STATUS- DOES IT EXIST AND CAN IT BE QUANTIFIED? INVESTIGATING EQ-5D IN SEVERE ASTHMA

    Oct 1, 2018, 00:00

  • PIN118 - KNOWLEDGE, ATTITUDE AND PRACTICES ABOUT ZIKA VIRUS AMONG PHARMACY STUDENTS IN THE UNITED STATES (US) AND INDIA- A CROSS SECTIONAL STUDY

    Oct 1, 2018, 00:00

  • PMU22 - ANTICHOLINERGIC BURDEN IN OLDER PATIENTS- PHARMACIST INTERVENTION

    Oct 1, 2018, 00:00

  • PRM133 - ESTIMATED COST SAVINGS FROM DOSE BANDING GUIDANCE- A CASE STUDY USING TREATMENTS FOR STAGE IV MELANOMA

    Oct 1, 2018, 00:00

  • PDB48 - ANNUAL COST OF ILLNESS OF ISCHEMIC STROKE IN TYPE 2 DIABETIC PATIENTS IN TURKEY

    Oct 1, 2018, 00:00

  • PHP357 - MAKING SENSE FROM ANTI-SENSE- LESSONS IN TRANSLATING EXPEDITED REGULATORY APPROVAL INTO REIMBURSEMENT AND COMMERCIAL SUCCESS

    Oct 1, 2018, 00:00

  • PMS54 - COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT AS FIRST LINE OF TREATMENT IN COLOMBIAN PATIENTS WITH PSORIATIC ARTHRITIS

    Oct 1, 2018, 00:00

  • PCP1 - COMPARISON OF THE GERMAN MIXED PRICE MODEL AND INDICATION-SPECIFIC PRICING FOR MULTI-INDICATION PRODUCTS IN ONCOLOGY

    Oct 1, 2018, 00:00

  • PCN93 - ECONOMIC MODELING FOR THE US OF INTRAVENOUS VS SUBCUTANEOUS RITUXIMAB IN NON-HODGKIN’S LYMPHOMA TREATED WITH R-CHOP

    Oct 1, 2018, 00:00

  • PMD163 - HTA OF ARTIFICIAL URINARY SPHINCTER (AUS) FOR THE TREATMENT OF SEVERE MALE POST-PROSTATECTOMY INCONTINENCE IN ITALY

    Oct 1, 2018, 00:00

  • DS1 - EPIDEMIOLOGY, TREATMENT, AND HEALTH RESOURCE USE OF GOUT PATIENTS IN GERMANY- RESULTS FROM ANALYSIS OF A CLAIMS DATABASE

    Oct 1, 2018, 00:00

  • PND2 - RISK OF PARKINSON’S DISEASE (PD) IN PATIENTS TAKING ADRENERGIC DRUG TREATMENTS

    Oct 1, 2018, 00:00

  • PDB27 - CLINICAL INERTIA IN RELATION TO BARRIERS TO PROGRESSION TO INJECTABLE THERAPY IN TYPE 2 DIABETES- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PHP330 - REAL-WORLD DATA COLLECTION ON MEDICAL DEVICES IN THE ERA OF VALUE-BASED HEALTHCARE- A LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PSY149 - IQVIA PATIENT DATA ASSESSMENT- REAL WORLD EVIDENCE IN THE MANAGEMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS

    Oct 1, 2018, 00:00

  • PHP358 - TIME-LIMITED G-BA RESOLUTIONS – A TOOL TO APPROPRIATELY MANAGE REIMBURSEMENT OF INNOVATIVE THERAPIES RECEIVING EXPEDITED REGULATORY APPROVAL

    Oct 1, 2018, 00:00

  • PMD179 - PATIENTS’ USABILITY OF SIX MOST USED DRY-POWDER INHALERS IN ASTHMA AND COPD

    Oct 1, 2018, 00:00

  • PND41 - HEALTHCARE COSTS OF PATIENTS WITH SPINAL MUSCULAR ATROPHY

    Oct 1, 2018, 00:00

  • PRM41 - ESTIMATION OF HOSPITAL COST SAVINGS ASSOCIATED WITH HYPOTENSION REDUCTION IN SEPTIC INTENSIVE CARE UNIT PATIENTS IN FRANCE

    Oct 1, 2018, 00:00

  • PIN38 - CLINICAL AND ECONOMIC IMPACT OF THE TREATMENT OF CHRONIC HEPATITIS C IN PRISON INMATES IN SPAIN

    Oct 1, 2018, 00:00

  • PHP106 - IMPACT OF ACCESS RESTRICTION ON USE OF SHORT-ACTING PRESCRIPTION OPIOIDS IN A US HEALTH PLAN

    Oct 1, 2018, 00:00

  • PMD146 - HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH ASEPTIC LOOSENING AFTER PRIMARY TOTAL KNEE ARTHROPLASTY

    Oct 1, 2018, 00:00

  • PRM47 - UNDERSTANDING KEY VALUE DRIVERS OF A NOVEL TREATMENT IN MANAGEMENT OF FAMILIAL CHYLOMICRONEMIA SYNDROME

    Oct 1, 2018, 00:00

  • PCN129 - TREATMENT COSTS AND PROGRESSION-FREE SURVIVAL OF DVD AND KRD REGIMENS SEQUENCES IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2018, 00:00

  • PHP183 - PRICE DIFFERENCE OF MEDICINES DISPENSED IN COMMUNITY PHARMACIES AND IN THE HOSPITAL SECTOR - AN ANALYSIS ON THE MEDICINES FINANCED ON THE BASIS OF HOSPITAL SERVICE TARIFFS

    Oct 1, 2018, 00:00

  • PMU99 - PERCEPTIONS OF THE GREEK POPULATION CONCERNING MEDICINES – A DESCRIPTIVE ANALYSIS

    Oct 1, 2018, 00:00

  • PHP116 - TREND IN OPIOID USE FROM 2001 THROUGH 2013 AMONG ELDERLY US VETERANS

    Oct 1, 2018, 00:00

  • PIN85 - TENOFOVIR ALAFENAMIDE’S IMPACT ON COMORBIDITIES AMONG PEOPLE LIVING WITH HIV IN PORTUGAL- A SIMULATION STUDY

    Oct 1, 2018, 00:00

  • PSY81 - DIRECT COSTS ASSOCIATED WITH THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RELAPSED OR REFRACTORY IN ARGENTINA

    Oct 1, 2018, 00:00

  • PCN332 - REAL-WORLD USAGE OF BORTEZOMIB IN COMBINATION WITH THALIDOMIDE AND DEXAMETHASONE (VTD) AS FRONTLINE (FL) TREATMENT IN STEM CELL TRANSPLANT (SCT) ELIGIBLE MULTIPLE MYELOMA (MM) PATIENTS ACROSS EU5 COUNTRIES

    Oct 1, 2018, 00:00

  • PRM77 - VALIDATION OF COPD ICD10 DIAGNOSTIC CODES IN THE SIDIAP PRIMARY HEALTH CARE RESEARCH DATABASE USING A COMBINATION OF SPIROMETRY MEASURES, SYMPTOMS, DRUG USE, AND FREE TEXT REVIEW.

    Oct 1, 2018, 00:00

  • PCP11 - ORGANISATIONAL MODELS AND OPPORTUNITIES FOR EFFICIENCY MEASURING IN HEALTH CARE

    Oct 1, 2018, 00:00

  • PSS60 - UTILITY ASSESSMENT FOR PEMPHIGUS HEALTH STATES USING VISUAL ANALOGUE SCALE AND TIME TRADE-OFF METHODS

    Oct 1, 2018, 00:00

  • PDB1 - ACUTE RENAL OUTCOMES WITH SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS- REAL WORLD DATA ANALYSIS

    Oct 1, 2018, 00:00

  • PMD61 - COST EFFECTIVENESS OF DERMABOND PRINEO SKIN CLOSURE SYSTEM IN HIP AND KNEE ARTHROPLASTY IN TURKEY

    Oct 1, 2018, 00:00

  • PDB93 - IMPACT OF CARDIOVASCULAR DISEASE ON HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH TYPE 2 DIABETES IN A REAL WORLD SETTING

    Oct 1, 2018, 00:00

  • PDB59 - COST-EFFECTIVENESS OF SWITCHING TO INSULIN DEGLUDEC (IDEG) U100 FROM CURRENTLY AVAILABLE BASAL INSULINS IN BELGIUM BASED ON EVIDENCE FROM REAL-WORLD CLINICAL PRACTICE

    Oct 1, 2018, 00:00

  • PRM67 - UTILITIES IN ONCOLOGY SUBMISSIONS SUBMITTED TO NICE —APPROACH OF THE MANUFACTURERS

    Oct 1, 2018, 00:00

  • PHP100 - UTILIZATIONS AND EXPENDITURES OF TUMOR NECROSIS FACTOR ANTAGONISTS IN MEDICARE PART D- CROSS- SECTIONAL STUDY (2014-2015)

    Oct 1, 2018, 00:00

  • PSS35 - SECUKINUMAB VERSUS USTEKINUMAB FOR THE TREATMENT OF PSORIASIS- A 52-WEEK COST PER RESPONDER ANALYSIS FROM THE PORTUGUESE PAYER PERSPECTIVE

    Oct 1, 2018, 00:00

  • PRM150 - TECHNOLOGY DIFFUSION IN HEALTHCARE- INSIGHTS FROM AN AGENT-BASED SIMULATION

    Oct 1, 2018, 00:00

  • PND27 - COST IMPLICATIONS IN THE SELECTION OF FIRST LINE TREATMENT FOR HIGHLY ACTIVE RELAPSING MULTIPLE SCLEROSIS IN PORTUGAL

    Oct 1, 2018, 00:00

  • PMD83 - CERVICAL CANCER SCREENING IN EUROPE - A SYSTEMATIC REVIEW ON COST EFFECTIVENESS STUDIES WITH SPECIFIC INTEREST ON RISK-ADAPTED STRATEGIES

    Oct 1, 2018, 00:00

  • PIN56 - COST-EFFECTIVENESS OF VARICELLA AND HERPES ZOSTER VACCINATION IN THE SWEDISH POPULATION

    Oct 1, 2018, 00:00

  • PMH60 - A COST-UTILITY ANALYSIS OF A MENTAL HEALTH PROMOTION PROGRAM IN SOCIAL ECONOMY COMPANIES IN FLANDERS

    Oct 1, 2018, 00:00

  • PHP117 - TRENDS OF PRESCRIPTION FOR OFF-LABEL DRUGS IN KOREAN PEDIATRIC PATIENTS USING CLAIMS DATA- WITH A FOCUS ON CLINICAL AREAS AND PRIMARY DISEASES

    Oct 1, 2018, 00:00

  • PIN8 - COMPARATIVE EFFICACY OF FIDAXOMICIN, VANCOMYCIN AND METRONIDAZOLE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION- A NETWORK META-ANALYSIS

    Oct 1, 2018, 00:00

  • PCN274 - TIME TO PRICE CHANGE FOLLOWING HTA DECISIONS

    Oct 1, 2018, 00:00

  • PRM256 - ADJUSTMENT FOR THE IMPACT OF SUBSEQUENT THERAPIES NOT AVAILABLE IN UK ON OVERALL SURVIVAL (OS) IN CASTOR TRIAL- A SUBGROUP ANALYSIS IN SECOND-LINE (2L) PATIENTS

    Oct 1, 2018, 00:00

  • PMS63 - COST-EFFECTIVENESS OF ACTONEL® 35 MG (RISEDRONATE) GASTRO-RESISTANT TABLETS FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN FRANCE

    Oct 1, 2018, 00:00

  • PND33 - PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS GLATIRAMER ACETATE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY

    Oct 1, 2018, 00:00

  • PSS67 - UNDERSTANDING THE PATIENT EXPERIENCE OF PRESBYOPIA AND IDENTIFICATION OF PATIENT-REPORTED OUTCOME ASSESSMENTS- A LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PCN123 - EVALUATION OF DRUG THERAPY COSTS FOR PATIENTS WITH BREAST CANCER, MELANOMA AND RENAL CELL CARCINOMA IN MOSCOW IN 2016-2017

    Oct 1, 2018, 00:00

  • PCV35 - SECONDARY PREVENTION FOR CARDIOVASCULAR DISEASE- DEFINITION OF POPULATION AND EVALUATION OF OUTCOMES USING REAL WORLD DATA

    Oct 1, 2018, 00:00

  • PSY114 - COST-EFFECTIVENESS OF VEDOLIZUMAB COMPARED WITH CONVENTIONAL THERAPY IN PATIENTS WITH CROHN’S DISEASE IN THE UNITED KINGDOM (UK)

    Oct 1, 2018, 00:00

  • PCV131 - IMPACT OF TIMELY INITIATION OF ANTIHYPERTENSIVE MEDICATIONS FOR PATIENTS WITH HYPERTENSION OR ELEVATED BLOOD PRESSURE

    Oct 1, 2018, 00:00

  • PCN99 - EVALUATING THE INCREASING STRAIN OF IMMUNOTHERAPIES (PD-1/PD-L1) ON PUBLIC HEALTHCARE SYSTEMS IN T5 + US

    Oct 1, 2018, 00:00

  • PND35 - HEALTHCARE, SICKNESS ABSENCE, AND DISABILITY PENSION COST TRAJECTORIES IN FIVE YEARS FOLLOWING MS DIAGNOSIS- REGISTER-BASED PROSPECTIVE COHORT STUDIES IN SWEDEN

    Oct 1, 2018, 00:00

  • PHP206 - TUMOUR-AGNOSTIC AGENTS- ARE THEY FIT FOR REIMBURSEMENT?

    Oct 1, 2018, 00:00

  • PHP235 - INDIRECT TREATMENT COMPARISONS (ITC) FOR HTA IN EUROPE – UNDERSTANDING REQUIREMENTS FOR INDUSTRY SUBMISSIONS

    Oct 1, 2018, 00:00

  • PCV4 - NON CARDIOVASCULAR COMORBITY AND PROGNOSIS OF CONGESTIVE HEART FAILURE

    Oct 1, 2018, 00:00

  • PSY143 - EPIDEMIOLOGY AND TREATMENT OF MICROSCOPIC COLITIS – REAL WORLD EVIDENCE FROM THE CZECH REPUBLIC

    Oct 1, 2018, 00:00

  • PHP105 - A POPULATION-BASED DATA ANALYSIS OF DRUG PRESCRIPTION AND PATTERNS OF USE OF ANTIBIOTIC IN SOUTHERN ITALY POPULATION

    Oct 1, 2018, 00:00

  • PSY62 - DIRECT COST OFFSETS RELATED TO BELIMUMAB SUBCUTANEOUS ADMINISTRATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN SPAIN

    Oct 1, 2018, 00:00

  • PMU15 - ANALYSIS OF THE METHODOLOGICAL OBJECTIONS REGARDING INDIRECT TREATMENT COMPARISON SUBMITTED TO THE HAUTE AUTORITÉ DE SANTÉ (HAS)

    Oct 1, 2018, 00:00

  • PCN223 - WHAT UNDERLIES THE OBSERVED HOSPITAL VOLUME-OUTCOME RELATIONSHIP?

    Oct 1, 2018, 00:00

  • PSY179 - IMPACT ANALYSIS OF THE PHARMACEUTICAL COVERAGE EXPANDING POLICY FOCUSED ON ANTICANCER RARE DISEASE IN KOREA

    Oct 1, 2018, 00:00

  • PHP237 - OVERVIEW OF GERMAN AMNOG DOSSIERS WITH PRICE ANALYSIS BEFORE AND AFTER EARLY BENEFIT ASSESSMENT

    Oct 1, 2018, 00:00

  • PMD100 - ECONOMIC EVALUATION OF PROTHROMBIN TIME TEST STRIPS (COAGUCHEK PRO II)

    Oct 1, 2018, 00:00

  • PCV107 - MULTI-CRITERIA DECISION ANALYSIS (MCDA) - DISCUSSION ABOUT THE INCORPORATION OF RIOCIGUAT IN THE TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) UNDER THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTHCARE SYSTEM (SUS)

    Oct 1, 2018, 00:00

  • PMH71 - AN ASSESSMENT OF HEALTH OUTCOMES BY PATIENT ACTIVATION LEVEL IN THE EU5

    Oct 1, 2018, 00:00

  • PND84 - PATIENT AND CAREGIVER BURDEN OF BOTULINUM TOXIN A INJECTIONS

    Oct 1, 2018, 00:00

  • PMD173 - TREATMENT DIFFERENCES IN CHILDREN BURN CARE IN GERMANY BETWEEN BURN CENTERS AND NON-CENTERS

    Oct 1, 2018, 00:00

  • QL1 - VALIDATION OF PROMIS PREFERENCE SCORE (PROPR) IN GERMAN PATIENTS WITH RHEUMATOLOGICAL CONDITIONS

    Oct 1, 2018, 00:00

  • PMU9 - PALLIATIVE CARE IN GERMANY- AN EPIDEMIOLOGICAL STUDY BASED ON REAL WORLD DATA

    Oct 1, 2018, 00:00

  • PCN227 - ACCESS TO ESSENTIAL ANTINEOPLASTICS AND IMMUNOSUPPRESSIVES

    Oct 1, 2018, 00:00

  • PCN344 - NUTRITION BEHAVIOUR OF PATIENTS WITH BREAST CANCER

    Oct 1, 2018, 00:00

  • PRS49 - COST-EFFECTIVENESS OF THE FIXED-DOSE COMBINATION TIOTROPIUM + OLODATEROL VERSUS TIOTROPIUM BASED ON THE DYNAGITO TRIAL RESULTS IN FRANCE

    Oct 1, 2018, 00:00

  • PIN90 - RECENT TRENDS IN MENINGOCOCCAL DISEASE-RELATED INPATIENT CARE IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PMU1 - FREQUENCY OF REPORTABLE ADVERSE EVENTS IN HEALTH-RELATED SOCIAL MEDIA POSTS

    Oct 1, 2018, 00:00

  • PGI7 - ROBUST ESTIMATES CONCERNING THE HCV ELIMINATION STRATEGY IN GREECE. COMBINING THE RESULTS FROM TWO DIFFERENT MATHEMATICAL MODELS

    Oct 1, 2018, 00:00

  • AD4 - ARE PATIENT-REPORTED PERSISTENCE AND ADHERENCE TO TREATMENT FOR A CHRONIC DISEASE VALID OUTCOMES? AN EXAMPLE WITH OSTEOPOROSIS

    Oct 1, 2018, 00:00

  • PUK28 - ASSESSMENT OF CHALLENGES ASSOCIATED WITH DRUG INNOVATION IN ORPHAN RENAL DISEASE

    Oct 1, 2018, 00:00

  • PCV92 - EARLY HEALTH TECHNOLOGY ASSESSMENT OF TISSUE-ENGINEERED HEART VALVES IN THE AORTIC POSITION IN ELDERLY PATIENTS

    Oct 1, 2018, 00:00

  • PSS13 - BUDGET IMPACT ANALYSIS OF APREMILAST IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS IN GREECE

    Oct 1, 2018, 00:00

  • PCP70 - REGENERATIVE MEDICINE- A PROPOSED CLASSIFICATION FOR HEOR BASED ON THERAPEUTIC STRATEGY AND TECHNOLOGY TYPE

    Oct 1, 2018, 00:00

  • PSY97 - COST-EFFECTIVENESS ANALYSIS OF ENZYME REPLACEMENT THERAPY FOR TYPE 1 GAUCHER DISEASE

    Oct 1, 2018, 00:00

  • PMH20 - BUDGETARY IMPACT OF TREATING OPIOID ADDICTION IN THE DANISH MUNICIPAL SETTING

    Oct 1, 2018, 00:00

  • PCV53 - IS EDOXABAN MORE COST-EFFECTIVE THAN WARFARIN IN PREVENTION OF STROKE AND DEEP VEIN THROMBOSIS?

    Oct 1, 2018, 00:00

  • PIN97 - VALIDATING DATA ON HEPATITIS C TESTING IN THE UK IN THE PRIMARY CARE SETTING

    Oct 1, 2018, 00:00

  • PMH23 - REAL-WORLD COSTS AND BUDGET IMPACT OF LONG-ACTING INJECTION ATYPICAL ANTIPSYCHOTICS FOR THE MANAGEMENT OF SCHIZOPHRENIA IN FRANCE

    Oct 1, 2018, 00:00

  • PMS14 - CHILDHOOD OBESITY AND FRACTURE RISK- A REGION-WIDE LONGITUDINAL COHORT STUDY OF 466,000 CHILDREN AND UP TO 11 YEARS OF FOLLOW-UP

    Oct 1, 2018, 00:00

  • PMH18 - MARKOV MODEL FOR PREDICTING THE RISK OF DEVELOPING DEMENTIA IN ELDERLY ADULTS

    Oct 1, 2018, 00:00

  • PDB111 - TREND AND FACTORS ASSOCIATED WITH PREVENTABLE HOSPITALIZATION AMONG DIABETES MELLITUS PATIENTS IN A NATIONAL HEALTH INSURANCE PROGRAM

    Oct 1, 2018, 00:00

  • PND120 - TREATMENT DECISIONS ABOUT FIRST-LINE DISEASE-MODIFYING TREATMENTS (DMTS) IN RELAPSING REMITTING MULTIPLE SCLEROSIS- A SYSTEMATIC REVIEW OF PATIENT NEEDS AND PREFERENCES

    Oct 1, 2018, 00:00

  • PUK36 - COMPARISON OF PATIENT-REPORTED OUTCOMES IN RANDOMIZED CONTROLLED TRIALS AND IN OBSERVATIONAL STUDIES FOR OVERACTIVE BLADDER- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PHP38 - ENZYME REPLACEMENT THERAPIES WITHIN THE GERMAN HTA (AMNOG) PROCESS

    Oct 1, 2018, 00:00

  • PDB67 - ONCE-WEEKLY SEMAGLUTIDE VERSUS DULAGLUTIDE FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES IN PORTUGAL- A LONG-TERM COST-EFFECTIVENESS ANALYSIS BASED ON SUSTAIN 7

    Oct 1, 2018, 00:00

  • PHP85 - THE RISE OF THE NON-SUBMISSION – A WORRYING TREND FOR UK PATIENT ACCESS WITH ‘BREXIT’ APPROACHING

    Oct 1, 2018, 00:00

  • PRM217 - THE ONLINE VERSION OF EMPRO- A NEW PLATFORM SYSTEM FOR THE STANDARDIZED APPRAISAL OF PRO INSTRUMENTS.

    Oct 1, 2018, 00:00

  • PHP216 - HOW RESPONSIVE IS INDUSTRY TO VALUE BASED PROCUREMENT (VBP)?

    Oct 1, 2018, 00:00

  • PUK3 - STUDY OF DIABETIC NEPHROPATHY PREVALENCE AMONG TYPE 2 DIABETIC OUTPATIENTS WITH UNCONTROLLED GLYCEMIA

    Oct 1, 2018, 00:00

  • PSY184 - HTA AND REIMBURSEMENT CONSIDERATIONS FOR RARE DISEASES IN EUROPEAN MARKETS- WHAT ARE THE IMPLICATIONS FOR MANUFACTURERS?S?

    Oct 1, 2018, 00:00

  • PMH11 - E-THERAPIES IN PREVENTING AND TREATING EATING DISORDERS- REVIEW OF TRIALS AND REAL-WORLD EVIDENCE

    Oct 1, 2018, 00:00

  • HT7 - A REVIEW OF EFFICIENCY OPINIONS OF FRENCH ‘HAUTE AUTORITE DE SANTE’ (HAS) IN THE ONCOLOGY FIELD

    Oct 1, 2018, 00:00

  • PRM129 - DECISION ANALYTIC MODELS TO INFORM ABOUT THE OPTIMAL MAMMOGRAPHY SCREENING INTERVALS- A SYSTEMATIC REVIEW.

    Oct 1, 2018, 00:00

  • PND92 - ACCESS AND REIMBURSEMENT FOR CURRENT AND EMERGING ALZHEIMER’S DISEASE-MODIFYING THERAPIES IN THE EU5

    Oct 1, 2018, 00:00

  • PRM170 - UTILIZING PATIENT COLLAGES IN QUALITATIVE INTERVIEWS TO FACILITATE DATA COLLECTION IN PATIENTS DIAGNOSED WITH ULCERATIVE COLITIS

    Oct 1, 2018, 00:00

  • PCV20 - NUMBER NEEDED TO TREAT FOR ORAL ANTI-COAGULANTS VERSUS VKA IN STROKE PREVENTION IN ATRIAL FIBRILLATION

    Oct 1, 2018, 00:00

  • PRM255 - QUANTIFYING SYSTEMATIC ERROR IN UNANCHORED INDIRECT COMPARISONS- THE IN-SAMPLE METHOD

    Oct 1, 2018, 00:00

  • PIN25 - PROJECTED BURDEN OF VACCINE-PREVENTABLE DISEASES IN OLDER ADULTS IN THE UNITED STATES- IMPACT OF POPULATION AGING

    Oct 1, 2018, 00:00

  • PRM5 - PROFILING OF DISEASE SYMPTOMS AND ADVERSE EVENTS- DOES SOCIAL MEDIA AUGMENT TRADITIONAL APPROACHES?

    Oct 1, 2018, 00:00

  • PCN229 - COMPARISON OF SICKNESS BENEFIT AND SICK LEAVE DURATION IN ONCOLOGY ACROSS COUNTRIES

    Oct 1, 2018, 00:00

  • PCN217 - KEEPING UP WITH THE COMPARATORS- TRENDS IN TARGETED CANCER THERAPIES BECOMING RIGHT COMPARATORS FOR PAYERS

    Oct 1, 2018, 00:00

  • PGI11 - HIGH LEVELS OF REIMBURSED COST AND USE OF GASTROENTEROLOGICAL DRUGS IN FRANCE

    Oct 1, 2018, 00:00

  • PCV23 - TIME TO TREATMENT INTENSIFICATION IN NEW STATIN USERS

    Oct 1, 2018, 00:00

  • PDB14 - MOBILE APPS FOR MEDICATION ADHERENCE IN DIABETES

    Oct 1, 2018, 00:00

  • PCN53 - STRUCTURED LITERATURE REVIEW OF THE PREVALENCE OF MICROSATELLITE INSTABILITY HIGH (MSI-H) AND DEFICIENT MISMATCH REPAIR (DMMR) AMONG SOLID TUMORS

    Oct 1, 2018, 00:00

  • PIH12 - PHARMACOEPIDEMIOLOGY OF DRUGS IN PREGNANT WOMEN WITH EXTRAGENITAL PATHOLOGY

    Oct 1, 2018, 00:00

  • PHP240 - HEALTH TECHNOLOGY ASSESSMENTS OF BEVACIZUMAB BIOSIMILARS- COULD A DEMONSTRATION OF COST-EFFECTIVENESS CHANGE THE RECOMMENDATION FOR REIMBURSEMENT VERSUS THE ORIGINATOR?

    Oct 1, 2018, 00:00

  • PSY31 - COMPARISON OF THE ESTIMATED PREVALENCE OF DIAGNOSED HOMOCYSTINURIA AND PHENYLKETONURIA IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PUK10 - ANALYZING HEALTH-ECONOMIC EFFECTS OF A RENAL PRE-TRANSPLANT PATIENT-STRATIFICATION TOOL AT AN EARLY STAGE OF PRODUCT DEVELOPMENT

    Oct 1, 2018, 00:00

  • PRM37 - REPRODUCIBLE COST ANALYSIS MODELING AMONG DIFFERENT GEOGRAPHIC REGIONS- A CASE EXAMPLE OF DUAL-MOBILITY CUPS IN REVISION TOTAL HIP ARTHROPLASTY

    Oct 1, 2018, 00:00

  • PMU45 - ESTIMATING THE CLINICAL AND ECONOMIC BURDEN OF HYPERKALAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE OR HEART FAILURE

    Oct 1, 2018, 00:00

  • PMD174 - IMPACT OF MEDICAL DEVICE REGULATION ON FUTURE HTA’S AND REIMBURSEMENT DECISIONS IN GERMANY, FRANCE AND SWITZERLAND – WHAT IS BLOOMING HERE?

    Oct 1, 2018, 00:00

  • PHP273 - A REVIEW OF ISSUES AFFECTING THE EFFICIENCY OF DECISION MAKING IN THE NICE SINGLE TECHNOLOGY APPRAISAL PROCESS

    Oct 1, 2018, 00:00

  • PMH68 - TREATMENT DISRUPTION AMONG PATIENTS WITH PARKINSON’S DISEASE WITH PSYCHOSIS ENROLLED IN US CENTERS FOR MEDICARE SERVICES

    Oct 1, 2018, 00:00

  • PSY213 - WHAT MATTERS TO INDIVIDUALS WITH SICKLE CELL DISEASE? PATIENT INPUT ON THE RELEVANT AND IMPORTANT SYMPTOMS AND IMPACTS OF THE CONDITION

    Oct 1, 2018, 00:00

  • PRM191 - LONGITUDINAL CONSTRUCT VALIDITY OF THE HEMOPHILIA CAREGIVER IMPACT MEASURE

    Oct 1, 2018, 00:00

  • PMD115 - THE DIAGNOSTIC METHODS AND COST OF LUNG CANCER IN GREECE

    Oct 1, 2018, 00:00

  • PMS79 - PHYSIOTHERAPY UTILIZATION INDICES IN HOME CARE IN HUNGARY

    Oct 1, 2018, 00:00

  • PIN126 - THE QUALITY OF LIFE (QOL) LOSS ASSOCIATED WITH INVASIVE MENNINGOCOCCAL B DISEASE (MENB) IN GERMANY

    Oct 1, 2018, 00:00

  • PSY171 - EXPECTED AND ACTUAL REIMBURSEMENT BASED ON CLINICAL PRACTICE GUIDELINE RECOMMENDATIONS IN TURKEY

    Oct 1, 2018, 00:00

  • Systematic Review and Network Meta-Analysis of Treatments for Chemotherapy-Naive Patients with Asymptomatic/Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer

    Oct 1, 2018, 00:00

  • PRS53 - COST-UTILITY ANALYSIS OF SQ® HDM SLIT-TABLET IN PATIENTS WITH HOUSE DUST MITE ALLERGIC RHINITIS WITH OR WITHOUT ALLERGIC ASTHMA IN POLAND

    Oct 1, 2018, 00:00

  • PMD85 - INDIRECT COMPARISON AND COST-EFFECTIVENESS ANALYSIS OF MINIMALLY INVASIVE ENDOVENOUS CYANOACRYLATE GLUE OCCLUSION, SURGICAL AND OTHER TREATMENT OPTIONS IN CHRONIC VENOUS INSUFFICIENCY

    Oct 1, 2018, 00:00

  • PDB52 - ANNUAL COST OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN TURKEY

    Oct 1, 2018, 00:00

  • PCN266 - A REAL-WORLD DATA STUDY REGARDING HOSPITAL RESOURCES USE AND COSTS ASSOCIATED WITH BLADDER CANCER IN SPAIN

    Oct 1, 2018, 00:00

  • PCN84 - TOTAL COST OF CARE AND BUDGET IMPACT FOR PATIENTS WITH CLL TREATED WITH VENETOCLAX

    Oct 1, 2018, 00:00

  • PND132 - ECONOMIC BURDEN OF MIGRAINE IN BRAZIL- RESULTS FROM MY MIGRAINE VOICE SURVEY

    Oct 1, 2018, 00:00

  • PMD2 - STUDY OF STATINS EFFECTS ON COGNITIVE IMPAIRMENT AMONG OUTPATIENTS WITH TYPE 2 DIABETES MELLITUS

    Oct 1, 2018, 00:00

  • PMU35 - COST COMPARISON OF COMPLEMENTARY AND ALTERNATIVE MEDICINE SPECIALIZED UNIT IN SUS

    Oct 1, 2018, 00:00

  • PND110 - GENE THERAPY PRODUCTS – MARKET ACCESS SITUATION IN EU AND IN SLOVAKIA

    Oct 1, 2018, 00:00

  • PHP278 - GUIDELINES IN GERMAN EARLY BENEFIT ASSESSMENT – WHICH GUIDELINES ARE CONSIDERED BY FEDERAL JOINT COMMITTEE FOR DETERMINING THE APPROPRIATE COMPARATOR?

    Oct 1, 2018, 00:00

  • PMD68 - A COST-CONSEQUENCE ANALYSIS OF ANACONDA VERSUS PROPOFOL AND MIDAZOLAM IN THE LONG-TERM SEDATION OF CRITICALLY-ILL SURGICAL PATIENTS FROM THE UK NHS PERSPECTIVE

    Oct 1, 2018, 00:00

  • PMD140 - OUT-OF-POCKET PAYMENTS FOR MEDICAL DEVICES AND EQUITY IN HEALTHCARE FOR PATIENTS WITH PRIMARY LYMPHEDEMA IN FRANCE

    Oct 1, 2018, 00:00

  • PCP4 - DEVELOMENT OF A QUALITY MANAGEMENT SYSTEM FOR EUNETHTA AND THE PERMANENT EUROPEAN COLLABORATION ON HTA

    Oct 1, 2018, 00:00

  • PHP135 - CHANGES IN THE NUMBER OF DENTISTS IN EUROPEAN COUNTRIES BETWEEN 2000-2015

    Oct 1, 2018, 00:00

  • PCN135 - DOES PATIENT SELECTION CRITERIA TRANSLATE INTO COST SAVINGS IN PATIENTS WITH ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER CHEMOTHERAPY FAILURE IN SPAIN?

    Oct 1, 2018, 00:00

  • PCN226 - BIOSIMILARS AND THE REGULATION OF ONCOLOGICAL PREPARATIONS IN GERMANY

    Oct 1, 2018, 00:00

  • PMD170 - A RESEARCH ON HOSPITAL BASED-HEALTH TECHNOLOGY ASSESSMENT MODELS OF ACQUISITION OF MEDICAL DEVICES IN HOSPITALS- THE CASE OF TURKEY

    Oct 1, 2018, 00:00

  • PMD81 - COST EFFECTIVENESS ANALYSIS OF MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND FOR REFRACTORY PAINFUL BONE METASTASES

    Oct 1, 2018, 00:00

  • PCN390 - METASTATIC COLORECTAL CANCER (MCRC) - LITERATURE REVIEW ON QUALITY OF LIFE INSTRUMENTS

    Oct 1, 2018, 00:00

  • PCN249 - CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) AND DRIVERS OF ANTIEMETIC PRESCRIBING- RESULTS OF A QUALITATIVE IN-PRACTICE STUDY OF CLINICIANS FROM VARIOUS SETTINGS

    Oct 1, 2018, 00:00

  • PCP45 - THE ROLE OF CROSSOVER AND TREATMENT SWITCHING IN INDIRECT TREATMENT COMPARSON IN IMMUNO-ONCOLOGY

    Oct 1, 2018, 00:00

  • PSS36 - PHARMACOECONOMIC EVALUATION OF PHARMACOLOGICAL TREATMENT OPTIONS FOR PATIENTS WITH MODERATELY-SEVERE AND SEVERE PSORIASIS WITH BASE THERAPY RESISTANCE

    Oct 1, 2018, 00:00

  • PHP271 - THE GROWING IMPORTANCE OF DIGITAL CHANNELS IN FORMULARY DECISION MAKING IN THE US

    Oct 1, 2018, 00:00

  • PDB87 - A COST-OF-CONTROL ANALYSIS- ONCE-WEEKLY SEMAGLUTIDE REDUCES COST OF REACHING TREATMENT TARGETS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN NORWAY

    Oct 1, 2018, 00:00

  • PCN103 - PREDICTED TREATMENT COSTS AND SAVINGS PER PATIENT OF KANJINTI® (TRASTUZUMAB BIOSIMILAR) VS. SUBCUTANEOUS (SC) AND INTRAVENOUS (IV) HERCEPTIN® AND OTHER TRASTUZUMAB BIOSIMILARS IN ITALY

    Oct 1, 2018, 00:00

  • PRM50 - IMPROVEMENT OF EFFICIENCY OF SEVERE ATOPIC ASTHMA TREATMENT

    Oct 1, 2018, 00:00

  • PCN7 - A TIME WITHOUT SYMPTOMS OR TOXICITY ANALYSIS OF NIRAPARIB COMPARED WITH ROUTINE SURVEILLANCE IN THE MAINTENANCE TREATMENT OF PATIENTS WITH RECURRENT OVARIAN CANCER

    Oct 1, 2018, 00:00

  • PMD175 - MARKET ENTRY OF NEW MEDICAL DEVICES IN GERMANY - OUTPATIENT SECTOR

    Oct 1, 2018, 00:00

  • PMS20 - BUDGET IMPACT OF INTRODUCING SECUKINUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS FROM THE PRIVATE PAYER PERSPECTIVE IN BRAZIL

    Oct 1, 2018, 00:00

  • PSS40 - COST-EFFECTIVENESS OF OCRIPLASMIN FOR THE TREATMENT OF VITREOMACULAR TRACTION, INCLUDING WHEN ASSOCIATED WITH MACULAR HOLE- A BELGIAN PERSPECTIVE

    Oct 1, 2018, 00:00

  • CN6 - COST-EFFECTIVENESS MODEL OF MIDOSTAURIN (MIDO) VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH NEWLY DIAGNOSED FLT3 MUTATION-POSITIVE (FLT3+) ACUTE MYELOID LEUKEMIA (AML)- A FRENCH PERSPECTIVE

    Oct 1, 2018, 00:00

  • PCN44 - FIRST-LINE TREATMENT EFFICACY IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER- A NETWORK META-ANALYSIS

    Oct 1, 2018, 00:00

  • PDB132 - TYPE 2 DIABETES TREATMENT PATHS AND PATIENT OUTCOMES IN RESPONSE TO REIMBURSEMENT POLICY CHANGE IN FINLAND

    Oct 1, 2018, 00:00

  • PDB29 - TYPE 2 DIABETES- DISCONTINUATION OF ANTIDIABETIC DRUG DISPENSING 8 YEARS AFTER STARTING TREATMENT- A NATIONWIDE COHORT STUDY USING THE FRENCH NATIONAL HEALTH DATA SYSTEM (SNDS)

    Oct 1, 2018, 00:00

  • PDB62 - COST-EFFECTIVENESS ANALYSIS OF EMPAGLIFLOZIN IN JAPAN BASED ON RESULTS FROM THE SUBGROUP ANALYSIS OF ASIAN PATIENTS IN THE EMPA-REG OUTCOME TRIAL

    Oct 1, 2018, 00:00

  • PHP163 - THE FRENCH HEALTH ECONOMIC RESEARCH PROGRAM(PRME)- AN OVERVIEW SINCE ITS CREATION IN 2013

    Oct 1, 2018, 00:00

  • PCV70 - EFFECT OF TIME IN THERAPEUTIC RANGE ON COST AND CLINICAL OUTCOMES OF ATRIAL FIBRILATION PATIENTS - A COST-CONSEQUENCES ANALYSIS OF RIVAROXABAN VS WARFARIN FOR TURKEY

    Oct 1, 2018, 00:00

  • Editorial Board

    Sep 20, 2018, 13:52

  • An Economic Evaluation of Migalastat Versus ERT for the Treatment of Fabry Disease in Japan

    Sep 1, 2018, 00:00

  • The Effect of Alternative Therapy Interventions On The Quality of Life of Dementia Patients- Meta-Analyses

    Sep 1, 2018, 00:00

  • Systematic Literature Review of Cost-Effectiveness Evaluations in Japan

    Sep 1, 2018, 00:00

  • Assessment of Knowledge, Perception and Attitude of Antibiotics use and Resistance Among the Medical and Paramedical Undergraduate Students of Gandaki Medical College Nepal

    Sep 1, 2018, 00:00

  • The Impact of Risk-Sharing Agreements on Drug Reimbursement Decisions in South Korea

    Sep 1, 2018, 00:00

  • Identify The Temporal Medication Pattern In The Hypertensive Patients Using Sequential Pattern Mining and Relate The Patterns To The Outcome and Cost

    Sep 1, 2018, 00:00

  • Current Situation, Causes, and Solutions to Drug Shortage in China—A Case Study of Jiangsu Province

    Sep 1, 2018, 00:00

  • A Locally Developed Quality of Life Measurement Scale for Family Caregivers of Patients with Advanced Cancers in Singapore

    Sep 1, 2018, 00:00

  • Perceptions of Self-Medication Practices And Awareness Regarding Its Complications- A Community –Based Study

    Sep 1, 2018, 00:00

  • Cost Minimization Study between Intravenous Rituximab (R-IV) vs Subcutaneous Rituximab (R-SC) in Thai Patients with Diffused Large B-CELL Lymphoma (DLBCL)- A Simulation of Electronic Health Record (E-HR) and Evidence Synthesis

    Sep 1, 2018, 00:00

  • The Identification of Patient-Centric Value Drivers for Self-Paid Treatments in Asia

    Sep 1, 2018, 00:00

  • Cross Cultural Study to Predict Academic Achievement of Malaysian and Thailand Pharmacy Students 2017

    Sep 1, 2018, 00:00

  • Patient Preference Study on Treatments of Non Small Cell Lung Cancer in Western China

    Sep 1, 2018, 00:00

  • Medical Costs of Hypoglycemia in Type 1 and Type 2 Diabetes Patients Using Basal Insulin Analogues in China- Based on Medical Record Data

    Sep 1, 2018, 00:00

  • Health States Utility Values In Osteoporosis Using Time Trade-Off

    Sep 1, 2018, 00:00

  • Accessibility and Equity of Current General Practitioner Distribution in China

    Sep 1, 2018, 00:00

  • The Impact of Quality of Life on Costs of Chronic Kidney Disease in China’s Four Metropolises

    Sep 1, 2018, 00:00

  • Incorporating Adherence in Cost-Effectiveness Analyses of Interventions for Asthma Treatment- A Systematic Review

    Sep 1, 2018, 00:00

  • The Cost-Effectiveness Analysis of Elbasvir/Grazoprevir Versus Peginterferon Αlpha-2A in Combination with Ribavirin in Patients with Chronic Hepatitis C Genotype 1b Infection in China

    Sep 1, 2018, 00:00

  • Incidence of Hip Fratures and Post Fracture Treatment In Women With Postmenopausal Osteoporosis In Taiwan

    Sep 1, 2018, 00:00

  • Trends in Health Information Technology Use Among Older People in The United States, 2009-2016

    Sep 1, 2018, 00:00

  • The Closure of Taiwan’s Small Hospitals and Changes in Patterns of Inpatient Care, From 2003 to 2012

    Sep 1, 2018, 00:00

  • Hta Outcomes for Orphan Drugs in Oncology- Comparison of France, Germany and England

    Sep 1, 2018, 00:00

  • An Overview of Systematic Reviews- Complementary Therapies for Cancer Patients

    Sep 1, 2018, 00:00

  • Inconsistency in Effectiveness Results in Pharmacoeconomic Models for Schizophrenia

    Sep 1, 2018, 00:00

  • Cost Effectiveness of a Novel Pre-Operative Skin Prep. Vs. Conventional Practi An Analysis to Aid Hospital Based Clinical Decision Making in India

    Sep 1, 2018, 00:00

  • Burden and Source Of Out-Of-Pocket Health Expenditures in India

    Sep 1, 2018, 00:00

  • Health Utility Scores in Patients With Type 2 Diabetes Mellitus in Indonesia

    Sep 1, 2018, 00:00

  • A Cost Claims Database Study with Propensity Score Applications in Covariates Selection and Balancing

    Sep 1, 2018, 00:00

  • Cost-Minimisation Analysis of Subcutaneous vs Intravenous Rituximab for the Treatment of Follicular Lymphoma and Diffuse Large B-Cell Lymphoma in Singapore

    Sep 1, 2018, 00:00

  • The Prevalence and Burden of Hypertension and Obesity Among Patients with Type 2 Diabetes in Urban China

    Sep 1, 2018, 00:00

  • Quality of Life of Various Hepatitis C Disease Stages in an Asian Middle Income Country- Data From Malaysia

    Sep 1, 2018, 00:00

  • Factors of High Asthma Expenditure in China- An 1-Year Retrospective Study

    Sep 1, 2018, 00:00

  • Factors Associated with Effectiveness of Population-Based Colorectal Cancer Screening

    Sep 1, 2018, 00:00

  • Healthcare Resource Utilization and Economic Burden of Herpes Zoster in Japanese Patients with Immunocompromised Conditions- A Claims Database Cohort Study

    Sep 1, 2018, 00:00

  • Do People With Crohn's Disease Value Health States Differently Based on Experience?

    Sep 1, 2018, 00:00

  • Medical Expenditure for Lung Cancer Per Clinical Visit in China- A 10-Year Multicenter Retrospective Survey (2002-2011)

    Sep 1, 2018, 00:00

  • Treatment Communication Between Patients With Serious Mental Illness (Smi) and Providers

    Sep 1, 2018, 00:00

  • The Health Economic Impact of Optimizing Post-Hospitalization Management For An Exacerbation in Copd Patients in China

    Sep 1, 2018, 00:00

  • Innovative Access Pathways for Digital Healthcare Solutions- Learnings From a European Analogue Analysis for Asian HTA Bodies

    Sep 1, 2018, 00:00

  • Adherence To Insulin In Singaporean Pediatric Type 1 Diabetes Patients And Its Association With Glycemic Control And Healthcare Utilization

    Sep 1, 2018, 00:00

  • Cost Analysis of Anti-Cancer Therapy in Ten Cancers in Taiwan

    Sep 1, 2018, 00:00

  • Budget Impact Analysis of Extended-Release Phenytoin Capsule (Original) Compared With Immediate-Release Phenytoin Capsule (Generic) for Epilepsy Patients in Thailand

    Sep 1, 2018, 00:00

  • Association Between Different Initial Date of Anti-Osteoporosis Medications With Subsequent Fracture-Related Hospitalization and Mortality- A Real-World Data Analyses 2008-2013

    Sep 1, 2018, 00:00

  • Smoking Trends in Japan From 2008-2017- Results From The National Health and Wellness Survey

    Sep 1, 2018, 00:00

  • Impact of Amnog on the Comparison of Orphan Drug Prices Between France and Germany

    Sep 1, 2018, 00:00

  • An Analysis of Price and Access Timeline of Oncology Drugs Across Eu5 Countries

    Sep 1, 2018, 00:00

  • Methodological Quality of Drug Safety Systematic Reviews- A Cross-Sectional Study

    Sep 1, 2018, 00:00

  • Cross-National Comparison of Biosimilar Medicines - Market Penetration and Competition with Originators

    Sep 1, 2018, 00:00

  • How Much do Malaysians Value Dengue Vaccine? Evaluating the Willingness to Pay (WTP) for Hypothetical Dengue Vaccine with Two-Part Model (TPM)

    Sep 1, 2018, 00:00

  • How Errors in the Implementation of Background Mortality Leads to Bias in Models

    Sep 1, 2018, 00:00

  • Using “Big Data” in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies- Challenges and Potential Solutions

    Sep 1, 2018, 00:00

  • Cost Analysis of Antibiotic Use in a Vietnamese Hospital

    Sep 1, 2018, 00:00

  • Health Insurance Burden of Sport Related Medical Problems- Treatment Cost of Dislocation and Sprain of Joints And Ligaments of Knee

    Sep 1, 2018, 00:00

  • A Comparison of Patient Characteristics Between Glp-1 Ra and Insulin Initiators in China

    Sep 1, 2018, 00:00

  • Economic Burden of Haze-Related Respiratory Illnesses in Selangor, Malaysia

    Sep 1, 2018, 00:00

  • Orphan Drug Policy and Access Dynamics in Japan

    Sep 1, 2018, 00:00

  • Dynamic Evaluation of Utilization of Innovative Oncology Drugs Under National Health Insurance System in Taiwan

    Sep 1, 2018, 00:00

  • Patient Involvement in Health Technology Assessments- An International Comparison

    Sep 1, 2018, 00:00

  • Health Care Utilization and Treatment Costs of the Patients with Hepatitis C Virus Infection in Zhengzhou, China

    Sep 1, 2018, 00:00

  • Trends and Patterns of Antibiotic Consumption in China- Evidence From A 5 Year Surveillance in Shandong Province, 2012-2016

    Sep 1, 2018, 00:00

  • Value-Based Healthcare Delivery - A Success Story for Taiwan ?

    Sep 1, 2018, 00:00

  • The Impact of Glycemic Control on Cognition in People with Type 2 Diabetes

    Sep 1, 2018, 00:00

  • The Effect of a Schizophrenia Pay-For-Performance Program on Patient Outcomes–Propensity Score Matching with Difference-In-Differences Design

    Sep 1, 2018, 00:00

  • Cost-Analysis of Posaconazole for Prophylaxis Against Fungal Infections in Patients with Hematological Malignancies in Qatar

    Sep 1, 2018, 00:00

  • Expert Consensus in the Development of A Pediatric Patient-Reported Outcome Measure for Korean Medicine Treatment- A Delphi Study

    Sep 1, 2018, 00:00

  • Electronic Cigarettes and Intention To Smoke Cigarettes Among Adolescents in Taiwan

    Sep 1, 2018, 00:00

  • Direct-to-Patient Contact- A Cost Effective Study Design Alternative for South East Asian and Rare-Disease Affiliate Groups Interested in Generating Local Real-World-Evidence Health Outcomes Data

    Sep 1, 2018, 00:00

  • Age and Gender Differences in Self-Reported Physical, Functional, and Mental Health in Taiwan

    Sep 1, 2018, 00:00

  • Survival And Healthcare Utilization After Venous Thromboembolism In Taiwan, A Nationwide Study

    Sep 1, 2018, 00:00

  • Coverage Gap For Prescription Drugs Among Children in The Us- Evidence From the National Health Interview Survey

    Sep 1, 2018, 00:00

  • Assessing Health-Related Quality of Life In Patients With Osteoporotic Vertebral Fractures- A Systematic and Standardized Comparison of Available Instruments Using The Empro Tool

    Sep 1, 2018, 00:00

  • Cost-Utility Analysis of Eox Drug Regimen Versus Dcf Drug Regimen for the Patients with Advanced Gastric Cancer in Shiraz in 2015

    Sep 1, 2018, 00:00

  • The Impact of Pre-Authorization Policy in the use of Colistin Antibiotic at King Salman Military Hospital Saudi Arabia

    Sep 1, 2018, 00:00

  • Markov Model Calibration of Weibull Distributed Transition Probabilities Using Scientific Python Optimization Packages

    Sep 1, 2018, 00:00

  • How Does G-BA Decision Impact Oncology Drug Prices in Germany?

    Sep 1, 2018, 00:00

  • A Pilot Study For Estimation Of Willingness-To-Pay Per Quality Adjusted Life Year (WTP PER QALY) as Cost Effectiveness Threshold in Indonesia

    Sep 1, 2018, 00:00

  • Are Time Trade-Off Values of Worse-Than-Death Health States Valid?

    Sep 1, 2018, 00:00

  • Are Orphan Drug Prices Fair?

    Sep 1, 2018, 00:00

  • A Study on Factors Influencing Drug Prices Among National Public Hospitals in the Philippines

    Sep 1, 2018, 00:00

  • Development of An Economic Model to Assess the Cost-Effectiveness of Proton Beam Therapy in Patients with Hepatocellular Carcinoma in Japan

    Sep 1, 2018, 00:00

  • Value-Based Health Care in Asia- Outcomes From Taiwan's Pay-For-Performance Programs

    Sep 1, 2018, 00:00

  • Analysis of Assisted Reproductive Technologies in Ukraine, Japan and Usa

    Sep 1, 2018, 00:00

  • Europe-China Comparison of Orphan Drugs Approvals

    Sep 1, 2018, 00:00

  • Financial Disclosure Statements

    Sep 1, 2018, 00:00

  • Descriptive Analysis of Drug Expense for Anti-Vascular Endothelial Growth Factor Therapy in Taiwan

    Sep 1, 2018, 00:00

  • Healthcare Utilization of Patient with Breast Cancer Following Exposure to Telemedical Care

    Sep 1, 2018, 00:00

  • Comparision of Child-Nursing Accident Sick-Pay and Accident Sick-Pay for Employees and Members of Individual and Corporate Enterprises in Hungary Between 2001-2016

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Immunotherapy Strategies for Advanced Melanoma in Taiwan

    Sep 1, 2018, 00:00

  • Systematic Review and Network Meta-Analysis of Randomized Trials of Surgery and Minimally Invasive Techniques Versus Cyanoacrylate Embolization for Varicose Veins

    Sep 1, 2018, 00:00

  • Modelling the Potential Impact of Pneumococcal Conjugate Vaccination in Thailand

    Sep 1, 2018, 00:00

  • Urinary Tract Infections-Incidence in Patients with Type 2 Diabetes Mellitus

    Sep 1, 2018, 00:00

  • Consumer Willingness-To-Pay and Preference for Skin Cancer Screening Services in Australia

    Sep 1, 2018, 00:00

  • Systematic Review of Economic Evaluations and Decision Models on Brca1/2-Mutations Related Health Interventions

    Sep 1, 2018, 00:00

  • Evaluating the Efficacy of Vaccinating Pigs Against Gonadotropin Releasing Factor (Gnrf) with Regards to Asian Consumers' Attitudes

    Sep 1, 2018, 00:00

  • Patient-Reported Outcomes in Observational Studies for Overactive Bladder- A Systematic Literature Review

    Sep 1, 2018, 00:00

  • Using EORTC QLQ-BR53 to Assess Health-Related Quality of Life in Women Breast Cancers

    Sep 1, 2018, 00:00

  • Cost Per-Responder Analysis of Secukinumab Compared To Other Biologics For The Treatment of Psoriatic Arthritis In Saudi Arabia

    Sep 1, 2018, 00:00

  • Comparing the Long-Term Impact on Healthcare Resources and Costs Due to Single-Piece Acrylic Intraocular Lens (IOL) Implantation During Cataract Surgery- A Cost-Consequence Analysis From Italian Healthcare System Perspective

    Sep 1, 2018, 00:00

  • Real-World Prescription Patterns and Comorbidity Burdens Among Adults with Nonalcoholic Fatty Liver Disease

    Sep 1, 2018, 00:00

  • Real World Health Insurance Cost of Femoral Neck Fracture In Hungary- A Nationwide Cost of Illness Study

    Sep 1, 2018, 00:00

  • Disability Adjusted Life Years for Liver Cancer in China- Trend Analysis from 1990-2016 and Future Prediction

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of A Randomized Controlled Trial to Reduce Fear of Cancer Recurrence

    Sep 1, 2018, 00:00

  • Cost of Treatment Analysis- Drug Therapy of Patients with Colorectal Cancer in Moscow

    Sep 1, 2018, 00:00

  • Trends in Medication Utilization, Glycemic Control, Rates of Severe Hypoglycemia and Lower Limb Amputations Among Type 2 Diabetes Patients with Chronic Kidney Disease in Singapore from 2012 to 2017

    Sep 1, 2018, 00:00

  • Epidemiological Characteristics, Medical Cost and Healthcare Resource Utilization of Diabetes-Related Complications Among Chinese Patients with Type 2 Diabetes Mellitus

    Sep 1, 2018, 00:00

  • Think Big (Biosimilar Inclusion Guide) for Our Children

    Sep 1, 2018, 00:00

  • Trends in Alcohol-Related Hospitalizations, Emergency Visits, Costs and Mortality in Singapore Between 2006 and 2016

    Sep 1, 2018, 00:00

  • A Cost-Benefit Analysis of The Second Generation Cessation Services Payment Scheme in Taiwan From A Societal Viewpoint

    Sep 1, 2018, 00:00

  • Efficacy and Safety in Self-Prepared Nasal Saline Irrigation and Clinical Outcome in Patient With Allergic Rhinitis

    Sep 1, 2018, 00:00

  • The Impact of Generic Drug Entry on Market Shares and Prices of Brand-Name Drugs– Evidence from Chinese Pharmaceutical Market

    Sep 1, 2018, 00:00

  • Comparison of Baseline Characteristics and Hospital Utilization Rates Between Asian American and White American Patients with Multiple Sclerosis in Hawaii

    Sep 1, 2018, 00:00

  • Stratification of Dengue Induced Acute Kidney Injury by Using Conventional, Akin and Rifle Definitions- A Comparative Analysis

    Sep 1, 2018, 00:00

  • Validation of Algorithms to Identify Acute Myocardial Infarction, Ischemic Stroke, and Hemorrhagic Stroke Cases from Japanese Claims Database

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Screening a 5 Year Old Child for Hearing Loss Using Sound Scouts Compared with no Screening- A Decision Model Analysis

    Sep 1, 2018, 00:00

  • Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacological Treatment for Chronic Obstructive Pulmonary Disease

    Sep 1, 2018, 00:00

  • Is The Oral Contraceptive Pill Rx to Otc Switch Cost-Effective?

    Sep 1, 2018, 00:00

  • Cost–Effectiveness of Remifentanil Versus Fentanyl in Adult Surgery Based on a Meta Analysis of Randomized Controlled Trials

    Sep 1, 2018, 00:00

  • Direct Medical Costs Associated with Opportunistic Infections in Hiv-Infected Patients in Taiwan

    Sep 1, 2018, 00:00

  • The Use of Simulation for Estimating Hospital Treatment Capacity in Dealing With Mass Casualty Incidents

    Sep 1, 2018, 00:00

  • Concept of Data Security and Outpatient Monitoring of General Health Status

    Sep 1, 2018, 00:00

  • Orphan Drugs- Health Technology Assessment and Pricing in Europe

    Sep 1, 2018, 00:00

  • Antidiabetic Drugs Prescription Spatial Variability

    Sep 1, 2018, 00:00

  • HTA Analysis of Cochlear Implant - Health Technology Assessment in Slovak Healthcare Environment

    Sep 1, 2018, 00:00

  • Cost- Effectiveness of Deep Molecular Response with First- Line Nilotinib vs. Imatinib in PH+ Chronic Myeloid Leukaemia Measured by Effectively Treated Patient- Years in Bulgaria

    Sep 1, 2018, 00:00

  • Effect of Methicillin Resistance on total Medical Cost Among Inpatients with Staphylococcus Aureus

    Sep 1, 2018, 00:00

  • Value-Based Pricing in Singapore- Is it a Race to the Bottom?

    Sep 1, 2018, 00:00

  • Early Predictors of Clinical Response at 8 Weeks in Patients with First-Episode Schizophrenia Treated with Risperidone

    Sep 1, 2018, 00:00

  • The Effect of HIP Fat on Health- Based on the Correlation Analysis Between HIP Circumference and Quality of Life

    Sep 1, 2018, 00:00

  • Systematic Analysis and Quality Evaluation of Pharmacoeconomics Researches on Traditional Chinese Medicines

    Sep 1, 2018, 00:00

  • Cost-Minimisation Analysis of Subcutaneous Versus Intravenous Trastuzumab for the Treatment of Early Breast Cancer and Metastatic Breast Cancer in Singapore

    Sep 1, 2018, 00:00

  • Statin use and Early Onset Cataract：A Population Based Case Control Study

    Sep 1, 2018, 00:00

  • Increased Length of Stay- Identification of Predictors in Patients With Diabetic Foot Surgery

    Sep 1, 2018, 00:00

  • Effectiveness of A Short Training For Community Pharmacists To Improve Knowledge And Practice in Asthma Counselling – A Simulated Patient Method

    Sep 1, 2018, 00:00

  • A Cross Country Comparison of the Reimbursement Requirements in Endemic and Non-Endemic Settings- An Application to a Dengue Vaccine

    Sep 1, 2018, 00:00

  • Factor Dispensation and Expenditures in Hemophilia B Patients Switching from Standard Half-Life to Extended Half-Life Recombinant Factor IX Replacement Products- Real-World Analysis in Japan

    Sep 1, 2018, 00:00

  • An Investigation of Minor Ailments Management By Elderly in Non-Urban Areas

    Sep 1, 2018, 00:00

  • Medical Cost Estimation for Elderly Acute Myeloid Leukemia (Aml) Using Real World Data in Japan

    Sep 1, 2018, 00:00

  • Trends in Prevalence of Statin Use and Treatment Burden for Statin Users with Comorbidities in South Korea

    Sep 1, 2018, 00:00

  • A 10- Year Global Epidemiological Forecast Of Atrial Fibrillation

    Sep 1, 2018, 00:00

  • Estimating Cost of Diabetes and its Complications in Indonesia, Vietnam and the Philippines using National Claims Databases

    Sep 1, 2018, 00:00

  • HBA1C As A Risk Factor For Cardiovascular Disease in Type 2 Diabetes Mellitus- A Hospital-Based Study in Taiwan

    Sep 1, 2018, 00:00

  • Pharmacoeconomic Evaluation of Bariatric Surgery Program in Morbidly Obese Diabetes Mellitus Type Two Patients in Thailand

    Sep 1, 2018, 00:00

  • Impact of Comorbid Substance Abuse on Healthcare Utilization And Costs In Patients with Bipolar I Disorder Treated With Atypical Antipsychotics

    Sep 1, 2018, 00:00

  • The Place of Ehealth Interventions in the Management Pathway of Inflammatory Bowel Disease (Ibd) Patients- A Systematic Review

    Sep 1, 2018, 00:00

  • Health-Related Quality of Life in Japanese Patients with Prostate Cancer Using EQ-5D-5L and FACT-P- Comparisons According to Treatment Type

    Sep 1, 2018, 00:00

  • Economic Burden of Atrial Fibrillation in Japan

    Sep 1, 2018, 00:00

  • A Meta-Analysis of Randomized Controlled Trials Comparing Once-Weekly Semaglutide to Control Therapy for the Treatment of Type 2 Diabetes

    Sep 1, 2018, 00:00

  • Comparison of Clinical Burden of Hcv Infection Between Asia and Europe- an Overview of Systematic Review

    Sep 1, 2018, 00:00

  • Direct Medical Costs Associated with Cardiovascular Diseases Among the HIV-Infected Patients in Taiwan- A Population-Based Study

    Sep 1, 2018, 00:00

  • Health Insurance Cost of Raynaud Syndrome In Hungary- A Nationwide Cost of Illness Study

    Sep 1, 2018, 00:00

  • On the Value of the Umbilical Cord Blood Supply

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Vedolizumab for the Management of Moderate-To-Severe Ulcerative Colitis in Thailand

    Sep 1, 2018, 00:00

  • Factors Affecting the Convenience of Cancer Patients for Drug Clinical Trials in Turkey- Final Analysis of A Multicenter Study

    Sep 1, 2018, 00:00

  • Comparative Study of Prostatic Transuretral Resection Versus Prostatic Photovaporization with Green Light XPS 180W Laser in the Treatment of the Benign Prostatic Hyperplasia- Cost-Effectiveness Analysis

    Sep 1, 2018, 00:00

  • CORRECTION

    Sep 1, 2018, 00:00

  • Health Insurance Coverage and Statin Prescription Among Adults in The US

    Sep 1, 2018, 00:00

  • Humanistic and Economic Burden of HCV Infection- An Overview of Systematic Review

    Sep 1, 2018, 00:00

  • Burden of Illness Associated with Influenza Virus Infection in Japan- A Literature Review

    Sep 1, 2018, 00:00

  • Common Errors Made in Analyzing Japanese Claims Databases and how to Avoid them

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Durvalumab after Chemoradiation in Stage III Non-Small Cell Lung Cancer (Nsclc)

    Sep 1, 2018, 00:00

  • Budget Impact of Orbital Atherectomy Compared to Rotational Atherectomy in Patients with Severely Calcified Coronary Artery Lesions in Japan

    Sep 1, 2018, 00:00

  • Anxiety and Insomnia Among Elderly People in Chonburi, Thailand 2017

    Sep 1, 2018, 00:00

  • The “Second Negotiation” Policy in Chinese Hospitals

    Sep 1, 2018, 00:00

  • Willingness to Pay Per Quality-Adjusted Life in Taiwan

    Sep 1, 2018, 00:00

  • Pharmacist Involvement with Elderly Patients with Polypharmacy to Decrease Medical Service Use- Experience in Taiwan

    Sep 1, 2018, 00:00

  • Burden of Ischemic Heart Disease And Stroke And Impact of Lipid Control And Modifiable Risk Factors In China

    Sep 1, 2018, 00:00

  • Quality-Adjusted Life-Years without Constant Proportionality

    Sep 1, 2018, 00:00

  • The Interactions Between Underlying Risk Factors And Climate Changes In The Occurrence Of Acute Myocardial Infarction – A Nationalwide Study

    Sep 1, 2018, 00:00

  • Differences In ADL At Admission And Discharge For Stroke Patients

    Sep 1, 2018, 00:00

  • Evaluation of the Healthcare Costs and Utilization of Patients with Metastatic Breast Cancer

    Sep 1, 2018, 00:00

  • Pharmacoeconomics Education in Schools of Pharmacy in Japan- A Questionnaire Survey

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Rivaroxaban and Aspirin Compared to Aspirin Alone in Patients with Stable Cardiovascular Disease- An Australian Perspective

    Sep 1, 2018, 00:00

  • Hospital Cost Savings Associated with Flowable Gelatin Hemostat for Anterior Cervical Spine Surgery in Chinese Patients- A Real-World Retrospective Cohort Study

    Sep 1, 2018, 00:00

  • Cost-Utility Analysis of Colorectal Cancer Treatment in A Third Level Public Hospital in Mexico

    Sep 1, 2018, 00:00

  • Health Insurance Burden of Sport Related Medical Conditions- Treatment Cost of The Injuries of Lower Leg

    Sep 1, 2018, 00:00

  • Development and Validatin of A Practical Protocol For Improving The Quality Of Care of Patients Encounter Osteoporotic Fracture

    Sep 1, 2018, 00:00

  • Effect of Pharmacist’s Intervention on the Cost of Clinical Pathway for Gastric Cancer Operation

    Sep 1, 2018, 00:00

  • Studies on Economic Burden of Disease Using Real-World Healthcare Data in Japan- A Systematic Review

    Sep 1, 2018, 00:00

  • Differences in Postoperative Admission Days and Nursing Care Levels Depending on Type of Surgeries for Colon Cancer Patients

    Sep 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of u sing an Innovative Gradually Reducing Femoral Radius Design Implant VS. A Class of Metal-Backed Implants for Patients Undergoing Total Knee Arthroplasty (TKA) Surgery from an Indian Societal Perspective

    Sep 1, 2018, 00:00

  • Local Inputs for A Societal Perspective- Estimating the Friction Period in Australia

    Sep 1, 2018, 00:00

  • Evolution of Hta System in Japan- Progress and Conservatism

    Sep 1, 2018, 00:00

  • Adverse Drug Reaction Monitoring of Atypical Antipsychotics- Exploration and Establishment of Risk Factors

    Sep 1, 2018, 00:00

  • The Economic Burden of Sickle Cell Disease in the United States

    Sep 1, 2018, 00:00

  • Economic Analysis of Urea-Excipient Drug-Coated Balloon Therapy for Treatment of Femoropopliteal Artery Disease in Japan

    Sep 1, 2018, 00:00

  • Cost Analysis of Changing A Model of Care and Employing General Practitioners within Residential Aged Care Facilities Based on A Prospective, Stepped-Wedge, Cluster Randomised Trial in an Australian Setting

    Sep 1, 2018, 00:00

  • Analysis of Anticoagulation Therapy In Patients With Pulmonary Embolism Among The Population With Urban Basic Health Insurance In China

    Sep 1, 2018, 00:00

  • A Simulation Study of the Effect of Screening on Lung Cancer Mortality in Asia

    Sep 1, 2018, 00:00

  • Economic Impact of Delayed Access to Sofosbuvir-Based Regimen Under the Thai Universal Health Coverage (UHC)

    Sep 1, 2018, 00:00

  • Value-Based Decisions for Off-Patent Pharmaceuticals in Developing Countries – A Pilot Study Using Multi-Criteria Decision Analysis for Tenders in Indonesia

    Sep 1, 2018, 00:00

  • Reducing healthcare costs in antidepressant non-responders- does timing of antipsychotic augmentation matter?

    Sep 1, 2018, 00:00

  • Treatment patterns, health care resource utilization and costs in patients affected by schizophrenia in italy- findings from a retrospective administrative database analysis

    Sep 1, 2018, 00:00

  • Cost Per-Responder Analysis of Secukinumab Compared to Other Biologics for Treatment of Moderate to Severe Psoriasis Patients in Saudi Arabia

    Sep 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of Neuraminidase Inhibitors for Influenza Virus Infection in Japan

    Sep 1, 2018, 00:00

  • Estimating Quality Of Life In Advanced Heart Failure- Can We Differentiate Excellent Expert Clinician Proxies?

    Sep 1, 2018, 00:00

  • The Association of Quality of Primary Care and the Potentially Avoidable Emergency Department (Ed) Visit

    Sep 1, 2018, 00:00

  • How Useful are the Pharmacoeconomics Systematic Reviews for Decision Making on Anticancer Drugs? a Systematic Review of Methods, Gaps, and Quality

    Sep 1, 2018, 00:00

  • EQ-5D-5L Derived Population Norms for Health-Related Quality of Life for Hong Kong General Population

    Sep 1, 2018, 00:00

  • A Study of Determinants of Hospitalizations in India

    Sep 1, 2018, 00:00

  • Economic Impact of Pharmacy Resident's Interventions in Medical Intensive Care Unit of University Hospital in Thailand

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Down-Scheduling Triptans in Australia

    Sep 1, 2018, 00:00

  • Determinants of Unmet Needs and Impact on Ambulatory Health Care Expenditures

    Sep 1, 2018, 00:00

  • 180-Day Mortality and Its Predictors In Women With Contralateral Hip Fracture After Femoral Neck Fracture

    Sep 1, 2018, 00:00

  • Methods Used for the Applicability of Real-World Data Sources to Individual Patient Decision Making

    Sep 1, 2018, 00:00

  • Cost-Effectiveness Of Internet-Delivered Cognitive Behaviour Therapy For Adolescents With Irritable Bowel Syndrome

    Sep 1, 2018, 00:00

  • Economic Burden of Needle-Stick Injury Among Healthcare Workers in China

    Sep 1, 2018, 00:00

  • A Novel, Simple and Accurate Method to Map Quality-Of-Life Scores to Utility Values

    Sep 1, 2018, 00:00

  • Adjunctive Atypical Antipsychotic (Aap) Choice Affects Healthcare Utilization in Major Depressive Disorder (Mdd)

    Sep 1, 2018, 00:00

  • From Per-Diem Payment to Case-Based Per-Episode Payment for Acute Mental Disorders in Guangzhou, China- A Propensity Score Matching and Difference-in-Differences Analysis Using Real World Data

    Sep 1, 2018, 00:00

  • Application of Real-World Evidence to Assess Outcomes After Surgical Treatment for Benign Prostatic Hyperplasia

    Sep 1, 2018, 00:00

  • Is the risk of developing depressive disorder following osteoarthritis and rheumatoid arthritis different?

    Sep 1, 2018, 00:00

  • Rates of Patient-Reported Outcome Claims for Orphan Drugs Approved by the European Medicines Agency

    Sep 1, 2018, 00:00

  • Dabigatran vs. Warfarin for Treatment of Atrial Fibrillation

    Sep 1, 2018, 00:00

  • Fitting A Model of Dengue Transmission to Empirical Data- Example of Rayong Province in Thailand

    Sep 1, 2018, 00:00

  • Health Related Income Loss in India- Are Acute Health Conditions Expensive?

    Sep 1, 2018, 00:00

  • Patient Complexity and Services Provided of Local Clinics in Taiwan- How Many of Them are “Primary Care” Providers?

    Sep 1, 2018, 00:00

  • Antibiotic use in a Clinical Department of a University Hospital in Vietnam

    Sep 1, 2018, 00:00

  • Health Economics of Orphan Drugs in Japan

    Sep 1, 2018, 00:00

  • Impact of Pharmacists' Assistance in Care of Asthma Patients in A Tertiary Care Hospital

    Sep 1, 2018, 00:00

  • Assessing the Value of Next-Generation Sequencing Technologies- An Introduction

    Sep 1, 2018, 00:00

  • Patient-Reported Outcome Measures for Medical Devices in Asia- A Literature Review

    Sep 1, 2018, 00:00

  • Fluorodeoxyglucose Positron Emission Tomography with Computerised Tomography for Oncological Indications- A Pragmatic Approach to Guide Subsidy Decisions

    Sep 1, 2018, 00:00

  • The Burden of Illness in Duchenne Muscular Dystrophy - How Much Evidence is Available?

    Sep 1, 2018, 00:00

  • Factors Impacting Direct Costs Of Chronic Kidney Disease Among Chinese Urban Patients In Pre-Dialysis Phase

    Sep 1, 2018, 00:00

  • Disease Burden of Chemotherapy and Chemoimmunotherapy Treatment of Relapse/Refractory Mantle Cell Leukemia (Rrmcl) Patients in China

    Sep 1, 2018, 00:00

  • Evaluation of the Efficacy of Acupuncture on Vascular Dementia After Stroke in Taiwan

    Sep 1, 2018, 00:00
  • «
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56 (current)
  • 57
  • 58
  • 59
  • 60
  • »